COVID-19-associated myocarditis: emerging pathogenic and diagnostic approaches
Vol. 6 No. 6 (2024), Original article
Vol. 6 No. 6 (2024)

COVID-19-associated myocarditis: emerging pathogenic and diagnostic approaches

Original article
https://doi.org/10.36557/2674-8169.2024v6n6p613-624
Published 2024-06-08
Lara Maria Silva Monteiro
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Edney Marcelo de Melo Aragão Júnior
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Leonardo Mota Silva
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Luís Bernardo Macedo Mata
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Dominique Montini Corneta Sarmento
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Gabriel Pereira Roque de Barros
Acadêmico de Medicina pelo Centro de Estudos Superiores de Maceió
Paulo Vytor Cardoso Nobre
Acadêmico de Medicina pela Universidade Federal de Alagoas
Sônia Wanderley Silva Persiano
Graduada em medicina pelo Centro Universitário de Maceió
José de Oliveira Melo Neto
Acadêmico de Medicina pela Faculdade de Medicina de Olinda
Ingrid Limbat Oliveira Araújo
Acadêmico de Medicina pela Faculdade de Medicina de Olinda
Jady Almeida de Melo Gusmão
Acadêmico de Medicina pela Faculdade de Medicina de Olinda
Maria Beatriz Guimarães Torres
Acadêmico de Medicina pela Faculdade de Medicina de Olinda
PDF (Português (Brasil))

Keywords

myocarditis associated with COVID-19; myocarditis; pathogenesis; diagnosis.

How to Cite

Monteiro, L. M. S., Júnior , E. M. de M. A., Silva, L. M., Mata, L. B. M., Sarmento, D. M. C., Barros, G. P. R. de, Nobre, P. V. C., Persiano, S. W. S., Neto, J. de O. M., Araújo , I. L. O., Gusmão , J. A. de M., & Torres , M. B. G. (2024). COVID-19-associated myocarditis: emerging pathogenic and diagnostic approaches. Brazilian Journal of Implantology and Health Sciences, 6(6), 613–624. https://doi.org/10.36557/2674-8169.2024v6n6p613-624
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Introduction: Myocarditis associated with COVID-19 is a myocardial inflammation that has been observed in patients infected by SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Objective: To evaluate the pathogenesis and diagnosis of myocarditis associated with COVID-19. Methodology: This is a bibliographic review that included original articles and systematic reviews in English and Portuguese, which addressed the pathogenic and diagnostic factors of myocarditis related to COVID-19, published between 2020 and 2024, selected from the PubMed, Scopus databases and SciELO. After careful selection, 31 articles were chosen to compose this bibliographic review. Results: The interaction of the virus with the cardiovascular system, through the ACE2 receptor, and the subsequent inflammatory immune response offer important insights into the underlying mechanisms and potential therapeutic targets. Diagnostic practices have adapted to protect healthcare professionals, emphasizing less invasive and safer tests, such as troponin measurement and the use of imaging techniques such as echocardiography and cardiac magnetic resonance (CMR). Considerations: the pathogenesis of myocarditis associated with COVID-19 is a field of intense investigation that continues to evolve. Careful and improved management of diagnostic procedures is essential to mitigate the devastating effects of this complication.

https://doi.org/10.36557/2674-8169.2024v6n6p613-624
PDF (Português (Brasil))

References

BAVISHI, C. et al. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis., 2020, art. 30123–30127. doi: S0033–0620(20)30123–30127.

BOEHMER, T. K. et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data—United States, March 2020-January 2021. MMWR Morb. Mortal. Wkly. Rep., 2021, v. 70, p. 1228-1232. doi: 10.15585/mmwr.mm7035e5.

CARO-CODON, J. et al. Characterization of NT-proBNP in a large cohort of COVID-19 patients. Eur. J. Heart Fail., 2021, v. 23, p. 456-464. doi: 10.1002/ejhf.2095.

CHEN, Q. et al. Simple Electrocardiographic criteria for Rapid Identification of Wide QRS Complex tachycardia: the new Limb Lead Algorithm. Heart Rhythm., 2020, v. 17, p. 431-438.

CLERKIN, K. J. et al. COVID-19 and cardiovascular disease. Circulation, 2020, v. 141, p. 1648-1655.

DI BIASE, L. et al. Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: impact of concomitant amiodarone therapy on short- and long-term clinical outcomes. Heart Rhythm., 2021, v. 18, p. 885-893.

ESPOSITO, A. et al. Cardiac magnetic resonance Characterization of myocarditis-like acute cardiac syndrome in COVID-19. JACC: Cardiovasc Imaging, 2020, v. 13, p. 2462-2465.

FOX, S. E. et al. Unexpected features of cardiac pathology in COVID-19 infection. Circulation, 2020, v. 142, p. 1123-1125.

FUDIM, M.; QADRI, Y. J.; GHADIMI, K. Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19. J Cardiovasc Transl Res., 2020, p. 1-6.

GAO, Z. et al. A systematic review of asymptomatic infections with COVID-19. J. Microbiol. Immunol. Infect., 2021, v. 54, p. 12-16. doi: 10.1016/j.jmii.2020.05.001.

GARCIA DE GUADIANA-ROMUALDO, L. et al. Cardiac troponin and COVID-19 severity: Results from BIOCOVID study. Eur. J. Clin. Invest., 2021, v. 51, art. e13532. doi: 10.1111/eci.13532.

GORDON, J. S.; DRAZNER, M. H. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review. Curr. Heart Fail. Rep., 2021, v. 18, p. 163-168. doi: 10.1007/s11897-021-00505-2.

HODGES, G. et al. Association between biomarkers and COVID-19 severity and mortality: A nationwide Danish cohort study. BMJ Open, 2020, v. 10, art. e041295. doi: 10.1136/bmjopen-2020-041295.

HUANG, C.; WANG, Y.; LI, X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, v. 395, n. 10223, p. 497-506.

INCIARDI, R. M. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol., 2020, v. 5, p. 819. doi: 10.1001/jamacardio.2020.1096.

KERMALI, M. et al. The role of biomarkers in diagnosis of COVID-19—A systematic review. Life Sci., 2020, v. 254, art. 117788. doi: 10.1016/j.lfs.2020.117788.

LIU, P. P. et al. The science underlying COVID-19: Implications for the cardiovascular system. Circulation, 2020, v. 142, n. 1, p. 68-78.

MELE, D. et al. Myocarditis in COVID-19 patients: current Problems. Intern Emerg Med., 2021, v. 16, p. 1123-1129.

MURK, W. et al. Diagnosis-wide analysis of COVID-19 complications: An exposure-crossover study. CMAJ, 2021, v. 193, p. E10-E18. doi: 10.1503/cmaj.201686.

OJHA, V. et al. Cardiac magnetic resonance imaging in coronavirus disease 2019 (COVID-19): a Systematic review of cardiac magnetic resonance imaging findings in 199 patients. J Thorac Imaging, 2021, v. 36, p. 73-83.

PRANATA, R. et al. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: Systematic review and meta-analysis. Postgrad. Med. J., 2020, v. 96, p. 387-391. doi: 10.1136/postgradmedj-2020-137884.

RAJPAL, S. et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol., 2021, v. 6, p. 116-118. doi: 10.1001/jamacardio.2020.4916.

RICHARDSON, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city Area. JAMA, 2020, v. 323, p. 2052.

Robbins, Rebecca, and Peter S. Goodman. "Pfizer reaps hundreds of millions in profits from covid vaccine." Brazilian Journal of Implantology and Health Sciences 3.9 (2021).

SANDOVAL, Y.; JANUZZI, J. L., Jr.; JAFFE, A. S. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J. Am. Coll. Cardiol., 2020, v. 76, p. 1244-1258. doi: 10.1016/j.jacc.2020.06.068.

SHANG, J.; YE, G.; SHI, K. Structural basis of receptor recognition by SARS-CoV-2. Nature, 2020, v. 581, n. 7807, p. 221-224.

SZEKELY, Y. et al. Spectrum of cardiac manifestations in COVID-19: a Systematic echocardiographic study. Circulation, 2020, v. 142, p. 342-353.

TAJBAKHSH, A. et al. COVID-19 and cardiac injury: Clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev. Anti. Infect. Ther., 2021, v. 19, p. 345-357. doi: 10.1080/14787210.2020.1822737.

TARANTINO, N. et al. Catheter ablation of life-threatening ventricular arrhythmias in Athletes. Medicina, 2021, v. 57, art. 205.

TAY, M. Z. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020, v. 20, n. 6, p. 363-374.

YOO, J. et al. Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19. ESC Heart Fail., 2021, v. 8, p. 4278-4287. doi: 10.1002/ehf2.13548.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Lara Maria Silva Monteiro, Edney Marcelo de Melo Aragão Júnior , Leonardo Mota Silva, Luís Bernardo Macedo Mata, Dominique Montini Corneta Sarmento, Gabriel Pereira Roque de Barros, Paulo Vytor Cardoso Nobre, Sônia Wanderley Silva Persiano, José de Oliveira Melo Neto, Ingrid Limbat Oliveira Araújo , Jady Almeida de Melo Gusmão , Maria Beatriz Guimarães Torres

Downloads

Download data is not yet available.
1 1